Transcription factor 4 is a key mediator of oncogenesis in neuroblastoma by promoting MYC activity.

IF 6.6 2区 医学 Q1 Biochemistry, Genetics and Molecular Biology
Nour A Aljouda, Dewan Shrestha, Chelsea DeVaux, Rachelle R Olsen, Satyanarayana Alleboina, Megan Walker, Yong Cheng, Kevin W Freeman
{"title":"Transcription factor 4 is a key mediator of oncogenesis in neuroblastoma by promoting MYC activity.","authors":"Nour A Aljouda, Dewan Shrestha, Chelsea DeVaux, Rachelle R Olsen, Satyanarayana Alleboina, Megan Walker, Yong Cheng, Kevin W Freeman","doi":"10.1002/1878-0261.13714","DOIUrl":null,"url":null,"abstract":"<p><p>Super-enhancer-associated transcription factor networks define cell identity in neuroblastoma (NB). Dysregulation of these transcription factors contributes to the initiation and maintenance of NB by enforcing early developmental identity states. We report that the class I basic helix-loop-helix (bHLH) transcription factor 4 (TCF4; also known as E2-2) is a critical NB dependency gene that significantly contributes to these identity states through heterodimerization with cell-identity-specific bHLH transcription factors. Knockdown of TCF4 significantly induces apoptosis in vitro and inhibits tumorigenicity in vivo. We used genome-wide expression profiling, TCF4 chromatin immunoprecipitation sequencing (ChIP-seq) and TCF4 immunoprecipitation-mass spectrometry to determine the role of TCF4 in NB cells. Our results, along with recent findings in NB for the transcription factors T-box transcription factor TBX2, heart- and neural crest derivatives-expressed protein 2 (HAND2) and twist-related protein 1 (TWIST1), propose a role for TCF4 in regulating forkhead box protein M1 (FOXM1)/transcription factor E2F-driven gene regulatory networks that control cell cycle progression in cooperation with N-myc proto-oncogene protein (MYCN), TBX2, and the TCF4 dimerization partners HAND2 and TWIST1. Collectively, we showed that TCF4 promotes cell proliferation through direct transcriptional regulation of the c-MYC/MYCN oncogenic program that drives high-risk NB. Mechanistically, our data suggest the novel finding that TCF4 acts to support MYC activity by recruiting multiple factors known to regulate MYC function to sites of colocalization between critical NB transcription factors, TCF4 and MYC oncoproteins. Many of the TCF4-recruited factors are druggable, giving insight into potential therapies for high-risk NB. This study identifies a new function for class I bHLH transcription factors (e.g., TCF3, TCF4, and TCF12) that are important in cancer and development.</p>","PeriodicalId":18764,"journal":{"name":"Molecular Oncology","volume":" ","pages":""},"PeriodicalIF":6.6000,"publicationDate":"2024-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/1878-0261.13714","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 0

Abstract

Super-enhancer-associated transcription factor networks define cell identity in neuroblastoma (NB). Dysregulation of these transcription factors contributes to the initiation and maintenance of NB by enforcing early developmental identity states. We report that the class I basic helix-loop-helix (bHLH) transcription factor 4 (TCF4; also known as E2-2) is a critical NB dependency gene that significantly contributes to these identity states through heterodimerization with cell-identity-specific bHLH transcription factors. Knockdown of TCF4 significantly induces apoptosis in vitro and inhibits tumorigenicity in vivo. We used genome-wide expression profiling, TCF4 chromatin immunoprecipitation sequencing (ChIP-seq) and TCF4 immunoprecipitation-mass spectrometry to determine the role of TCF4 in NB cells. Our results, along with recent findings in NB for the transcription factors T-box transcription factor TBX2, heart- and neural crest derivatives-expressed protein 2 (HAND2) and twist-related protein 1 (TWIST1), propose a role for TCF4 in regulating forkhead box protein M1 (FOXM1)/transcription factor E2F-driven gene regulatory networks that control cell cycle progression in cooperation with N-myc proto-oncogene protein (MYCN), TBX2, and the TCF4 dimerization partners HAND2 and TWIST1. Collectively, we showed that TCF4 promotes cell proliferation through direct transcriptional regulation of the c-MYC/MYCN oncogenic program that drives high-risk NB. Mechanistically, our data suggest the novel finding that TCF4 acts to support MYC activity by recruiting multiple factors known to regulate MYC function to sites of colocalization between critical NB transcription factors, TCF4 and MYC oncoproteins. Many of the TCF4-recruited factors are druggable, giving insight into potential therapies for high-risk NB. This study identifies a new function for class I bHLH transcription factors (e.g., TCF3, TCF4, and TCF12) that are important in cancer and development.

转录因子 4 通过促进 MYC 的活性,是神经母细胞瘤肿瘤发生的关键介质。
超级增强子相关转录因子网络确定了神经母细胞瘤(NB)的细胞身份。这些转录因子的失调通过强化早期发育身份状态而促进了神经母细胞瘤的发生和维持。我们报告说,I类碱性螺旋-环-螺旋(bHLH)转录因子4(TCF4;又称E2-2)是一个关键的NB依赖基因,它通过与细胞身份特异性bHLH转录因子异源二聚体,对这些身份状态做出了重要贡献。敲除 TCF4 在体外能明显诱导细胞凋亡,在体内能抑制致瘤性。我们利用全基因组表达谱分析、TCF4染色质免疫沉淀测序(ChIP-seq)和TCF4免疫沉淀质谱分析来确定TCF4在NB细胞中的作用。我们的研究结果以及最近在 NB 中发现的转录因子 T-box 转录因子 TBX2、心脏和神经嵴衍生物表达蛋白 2(HAND2)和扭转相关蛋白 1(TWIST1)、提出TCF4在调节叉头盒蛋白M1(FOXM1)/转录因子E2F驱动的基因调控网络中的作用,该网络与N-myc原癌基因蛋白(MYCN)、TBX2以及TCF4二聚化伙伴HAND2和TWIST1合作控制细胞周期的进展。综上所述,我们发现 TCF4 通过直接转录调控 c-MYC/MYCN 致癌程序促进细胞增殖,而 c-MYC/MYCN 致癌程序是高风险 NB 的驱动力。从机理上讲,我们的数据提出了一个新发现,即TCF4通过招募多个已知调控MYC功能的因子到关键NB转录因子、TCF4和MYC癌蛋白的共定位点,从而支持MYC的活性。TCF4招募的许多因子都是可药用的,这为高风险NB的潜在疗法提供了启示。这项研究发现了一类 bHLH 转录因子(如 TCF3、TCF4 和 TCF12)在癌症和发育中的新功能。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Molecular Oncology
Molecular Oncology Biochemistry, Genetics and Molecular Biology-Molecular Medicine
CiteScore
11.80
自引率
1.50%
发文量
203
审稿时长
10 weeks
期刊介绍: Molecular Oncology highlights new discoveries, approaches, and technical developments, in basic, clinical and discovery-driven translational cancer research. It publishes research articles, reviews (by invitation only), and timely science policy articles. The journal is now fully Open Access with all articles published over the past 10 years freely available.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信